Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors

Authors

Agostina Stradella, L'Hospitalet de Llobregat
Haeseong Park, Washington University School of Medicine in St. Louis
et al.

Journal

Cancer Medicine

Publication Date

7-1-2024

Volume

13

Issue

13

First Page

e7385

Document Type

Open Access Publication

DOI

10.1002/cam4.7385

Rights and Permissions

Stradella A, Johnson M, Goel S, et al. Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors. Cancer Med. 2024; 13:e7385. doi:10.1002/cam4.7385 © 2024 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Stradella, Agostina; Park, Haeseong; and et al., "Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors." Cancer Medicine. 13, 13. e7385 (2024).
https://digitalcommons.wustl.edu/oa_4/6016

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.